HIV-Blocking Pill Could Hit Market Soon

It could soon be a goodbye to the condom and a big hello a pill that prevents HIV infection. A drug that does that has been endorsed on a federal level in the United States.

The Food and Drug Administration Agency has approved the daily use of the drug Truvada for healthy people in vulnerable groups – gay and bisexual men as well as heterosexual people with an infected partner.

It is expected that a final decision will be made on the 15th of June paving the way for the drug to hit the market.

The catch though is that for it to work you have to take the dosage diligently. It means that you cannot miss a day or else the level of protection is compromised.

Truvada first hit the limelight in 2010 when it was discovered that it reduced HIV infection in gay men by 42%.  Then last year it was revealed that for heterosexual couples the risk was reduced by a whooping 78%.

But Truvada is not for everyone. It retails at about $900 per month which is a lot more than what most people in Zimbabwe can even dream of affording. Given the fact the most vulnerable people are the ones who at most risk, you realise that certain treatments are not based on a right to live but on who is in a position to buy life.

While we think that this new option is helpful we think that people should not be so quick to throw away the faithful condom. The existence of the drug doesn’t mean that one can go poking without protection. That would just be downright silly. A false sense of security is not a good look.